Biostage to Host Investor Call
HOLLISTON, Mass., June 13, 2023 /PRNewswire/ — Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, including cancer, trauma and birth defects initially in the esophagus and the airway, announced today that it will host an investor call on Tuesday, … Read more